RespireRx Pharmaceuticals Inc. ('RespireRx” or the 'Company”), a leader in the discovery and development of innovative and revolutionary treatments to combat diseases caused by disruption of neuronal ...

The RespireRx Group holds exclusive licenses and owns patents and patent applications or rights thereto for certain families of chemical compounds that claim the chemical structures and their uses in ...

On November 13, 2025, effective November 14, 2025 the Securities and Exchange Commission (“Commission”), in Administrative Proceeding File No. 3-22541, in Release No. 104178 issued an Order Making ...

Fortunately, there are steps any American can take. Everybody can assist in funding more research, even with as little as $20 ...

In 2025, the Trump administration froze or ended about 5,300 NIH and NSF research grants totaling over $5 billion in unspent funds, a decision that reshaped many fields of science.

Alejandro Alvarez-Prats breaks down his career journey the impact of funding cuts, and lessons the international scientific ecosystem can share.

Battles between the Trump administration and academic institutions are putting important biomedical advances in limbo.

The NIH cuts affected over 115 clinical trials studying cancer and nearly 100 studying infectious disease, researchers found.

The National Institutes of Health awarded more than $8 million to the Kennedy Krieger Institute for researching rare ...

Jennifer Munson, a cancer researcher at Virginia Tech's Fralin Biomedical Research Institute at VTC, has been awarded two new National Institutes of Health grants to advance greater understanding and ...

A lightning-fast imaging method is exposing the hidden mechanics of brain-cell communication and offering new clues to Parkinson’s origins.

BOSTON, MA — A federal judge has blocked a controversial policy by the National Science Foundation (NSF) that would have sharply limited the amount of grant money universities could use for overhead ...